Corporate resilience during COVID-19
The authors study whether during the 2020 COVID-19 induced market crash, investors differentiate across companies based on a firm’s human capital, supply chain and operating crisis response.
Europe’s response to COVID-19
European real GDP is now projected to contract by 7 per cent in 2020, its biggest decline since World War II, followed by a rebound of 4.7 per cent in 2021. But the recovery’s strength will depend crucially on the course of the pandemic, people’s behavior, and the degree of continued economic policy support.
Sort content by
COVID-19 treatment and vaccine tracker
The Milken Institute is tracking the development of treatments and vaccines for COVID-19. There are currently more than 2.5 million confirmed cases globally, 114 treatments in consideration and 79 vaccines in development.
Pandemic I: The first modern pandemic
In this memo Bill Gates shares his views of how to accelerate global innovation, which is the key to limiting the damage to society and the economy. This includes innovations in testing, treatments, vaccines, and policies to limit the spread while minimizing the damage to economies and well-being.
The economics of a pandemic
This lecture by professors of economics at the London Business School looks at the science, health policies, economics and macroeconomic policies related to COVID-19.
How the G20 can hasten recovery
This report argues the G20 not only should but can be meaningfully useful to recovery from the COVID-19 pandemic. It looks at the role of G20 in designing a fiscal response, strengthening access to vital medical supplies and ensuring global food security.
COVID-induced economic uncertainty
This paper identifies three indicators – stock market volatility, newspaper-based economic uncertainty, and subjective uncertainty in business expectation surveys – that provide real-time forward-looking uncertainty measures and illustrate how they can be used to assess the macroeconomic impact of the COVID-19 crisis. It implies a year-on-year contraction in US real GDP of nearly 11 per cent as of 2020 Q4
COVID-19 Research Hub